X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Insulin Glargine Companies

This report lists the top Insulin Glargine companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Insulin Glargine industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Insulin Glargine Top Companies

  1. Sanofi Aventis

  2. Novo Nordisk AS

  3. Biocon

  4. Eli Lilly and Company

  5. Julphar

*Disclaimer: Top companies sorted in no particular order

 Insulin Glargine Market Major Players

Insulin Glargine Market Concentration

Insulin Glargine Market Concentration

Insulin Glargine Company List

                        • Novo Nordisk AS

                        • Sanofi Aventis

                        • Eli Lilly and Company

                        • Biocon

                        • Julphar

                      • Company Share Analysis


                    Specific to Insulin Glargine Market
                    Need More Details On Market Players And Competitors?
                    Download PDF

                    Insulin Glargine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)